Search Results

There are 1835 results for: content related to: All-oral combination of ledipasvir, vedroprevir, tegobuvir, and ribavirin in treatment-naïve patients with genotype 1 HCV infection

  1. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  2. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  3. You have free access to this content
    Poster Session II (Abstracts 730 – 1194)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 361–601,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28798

  4. You have free access to this content
    Poster Session 4: Hepatitis C: New Agents (Not Approved)

    Hepatology

    Volume 60, Issue S1, October 2014, Pages: 1128A–1161A,

    Version of Record online : 1 OCT 2014, DOI: 10.1002/hep.27533

  5. Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy

    Hepatology Research

    Etsuko Iio, Noritomo Shimada, Koichi Takaguchi, Tomonori Senoh, Yuichiro Eguchi, Masanori Atsukawa, Akihito Tsubota, Hiroshi Abe, Keizo Kato, Atsunori Kusakabe, Tomokatsu Miyaki, Kentaro Matsuura, Kayoko Matsunami, Noboru Shinkai, Kei Fujiwara, Shunsuke Nojiri and Yasuhito Tanaka

    Version of Record online : 6 MAY 2017, DOI: 10.1111/hepr.12898

  6. You have free access to this content
    Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: An integrated safety and efficacy analysis

    Hepatology

    Volume 62, Issue 1, July 2015, Pages: 79–86, K. Rajender Reddy, Marc Bourlière, Mark Sulkowski, Masao Omata, Stefan Zeuzem, Jordan J. Feld, Eric Lawitz, Patrick Marcellin, Tania M. Welzel, Robert Hyland, Xiao Ding, Jenny Yang, Steven Knox, Phillip Pang, Hadas Dvory-Sobol, G. Mani Subramanian, William Symonds, John G. McHutchison, Alessandra Mangia, Edward Gane, Masashi Mizokami, Stanislas Pol and Nezam Afdhal

    Version of Record online : 9 MAY 2015, DOI: 10.1002/hep.27826

    Corrected by:

    Correction: Correction

    Vol. 62, Issue 5, 1646, Version of Record online: 29 AUG 2015

  7. Eight weeks of ledipasvir/sofosbuvir is effective for selected patients with genotype 1 hepatitis C virus infection

    Hepatology

    Volume 65, Issue 4, April 2017, Pages: 1094–1103, Kris V. Kowdley, Vinay Sundaram, Christie Y. Jeon, Kamran Qureshi, Nyan L. Latt, Amandeep Sahota, Stephen Lott, Michael P. Curry, Naoky Tsai, Nathorn Chaiyakunapruk, Yoori Lee, Jorg Petersen and Peter Buggisch

    Version of Record online : 25 FEB 2017, DOI: 10.1002/hep.29005

  8. Sofosbuvir plus ledispasvir for recurrent hepatitis C in liver transplant recipients

    Liver Transplantation

    Volume 22, Issue 11, November 2016, Pages: 1536–1543, Ryan M. Kwok, Joseph Ahn, Thomas D. Schiano, Helen S. Te, Darryn R. Potosky, Amber Tierney, Rohit Satoskar, Suzanne Robertazzi, Colleen Rodigas, Michelle Lee Sang, Joshua Wiegel, Neal Patel, Janet Gripshover, Mohamed A. Hassan, Andrea Branch and Coleman I. Smith

    Version of Record online : 26 OCT 2016, DOI: 10.1002/lt.24614

  9. You have free access to this content
    Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials

    Hepatology

    Volume 61, Issue 6, June 2015, Pages: 1798–1808, Zobair M. Younossi, Maria Stepanova, Patrick Marcellin, Nezam Afdhal, Kris V. Kowdley, Stefan Zeuzem and Sharon L. Hunt

    Version of Record online : 18 MAR 2015, DOI: 10.1002/hep.27724

  10. You have free access to this content
    Ledipasvir/sofosbuvir regimens for chronic hepatitis C infection: Insights from a work productivity economic model from the United States

    Hepatology

    Volume 61, Issue 5, May 2015, Pages: 1471–1478, Zobair M. Younossi, Yushan Jiang, Nathaniel J. Smith, Maria Stepanova and Rachel Beckerman

    Version of Record online : 23 MAR 2015, DOI: 10.1002/hep.27757

  11. You have free access to this content
    Plenary and Parallel Sessions (Abstracts 1–258)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 1–136,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28796

  12. Effectiveness and safety of sofosbuvir-based regimens plus an NS5A inhibitor for patients with HCV genotype 3 infection and cirrhosis. Results of a multicenter real-life cohort

    Journal of Viral Hepatitis

    Volume 24, Issue 4, April 2017, Pages: 304–311, S. Alonso, M. Riveiro-Barciela, I. Fernandez, D. Rincón, Y. Real, S. Llerena, F. Gea, A. Olveira, C. Fernandez-Carrillo, B. Polo, J. A. Carrión, A. Gómez, M. J. Devesa, C. Baliellas, Á. Castro, J. Ampuero, R. Granados, J. M. Pascasio, A. Rubín, J. Salmeron, E. Badia, J. M. M. Planas, S. Lens, J. Turnes, J. L. Montero, M. Buti, R. Esteban and C. M. Fernández-Rodríguez

    Version of Record online : 9 DEC 2016, DOI: 10.1111/jvh.12648

  13. Resistance Analyses of Japanese Hepatitis C-Infected Patients Receiving Sofosbuvir or Ledipasvir/Sofosbuvir Containing Regimens in Phase 3 Studies

    Journal of Viral Hepatitis

    Volume 23, Issue 10, October 2016, Pages: 780–788, M. Mizokami, H. Dvory-Sobol, N. Izumi, S. Nishiguchi, B. Doehle, E. S. Svarovskaia, S. De-Oertel, S. Knox, D. M. Brainard, M. D. Miller, H. Mo, N. Sakamoto, T. Takehara and M. Omata

    Version of Record online : 15 MAY 2016, DOI: 10.1111/jvh.12549

  14. Cardiorespiratory interactions: Noncontact assessment using laser Doppler vibrometry

    Psychophysiology

    Volume 53, Issue 6, June 2016, Pages: 847–867, Erik J. Sirevaag, Sara Casaccia, Edward A. Richter, Joseph A. O'Sullivan, Lorenzo Scalise and John W. Rohrbaugh

    Version of Record online : 11 MAR 2016, DOI: 10.1111/psyp.12638

  15. You have free access to this content
    Treatment of hepatitis C virus recurrence after transplantation with sofosbuvir/ledipasvir: The role of ribavirin

    Transplant Infectious Disease

    Volume 19, Issue 1, February 2017, Brigitta Globke, Nathanael Raschzok, Eva-Maria Teegen, Johann Pratschke, Eckart Schott and Dennis Eurich

    Version of Record online : 11 JAN 2017, DOI: 10.1111/tid.12647

  16. You have full text access to this OnlineOpen article
    Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells

    Immunity, Inflammation and Disease

    Volume 5, Issue 2, June 2017, Pages: 200–213, Mélanie Gaignage, Reece G. Marillier, Catherine Uyttenhove, Nicolas Dauguet, Anubha Saxena, Bernard Ryffel, Thomas Michiels, Jean-Paul Coutelier and Jacques Van Snick

    Version of Record online : 4 APR 2017, DOI: 10.1002/iid3.157

  17. You have free access to this content
    Poster Liver

    Journal of Gastroenterology and Hepatology

    Volume 30, Issue S4, December 2015, Pages: 323–407,

    Version of Record online : 24 NOV 2015, DOI: 10.1111/jgh.13189

  18. You have full text access to this OnlineOpen article
    The emergence of NS5B resistance associated substitution S282T after sofosbuvir-based treatment

    Hepatology Communications

    Volume 1, Issue 6, August 2017, Pages: 538–549, Edward J. Gane, Sophie Metivier, Ronald Nahass, Michael Ryan, Catherine A. Stedman, Evguenia S. Svarovskaia, Hongmei Mo, Brian Doehle, Hadas Dvory-Sobol, Charlotte Hedskog, Ming Lin, Diana M. Brainard, Jenny C. Yang, John G. McHutchison, Mark Sulkowski, Ziad Younes and Eric Lawitz

    Version of Record online : 22 JUN 2017, DOI: 10.1002/hep4.1060

  19. You have free access to this content
    Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 6, March 2015, Pages: 544–563, Z. M. Younossi, H. Park, S. Saab, A. Ahmed, D. Dieterich and S. C. Gordon

    Version of Record online : 26 JAN 2015, DOI: 10.1111/apt.13081

  20. Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries

    Journal of Viral Hepatitis

    Volume 23, Issue 3, March 2016, Pages: 217–226, Z. Younossi, A. Brown, M. Buti, S. Fagiuoli, S. Mauss, W. Rosenberg, L. Serfaty, A. Srivastava, N. Smith, M. Stepanova and R. Beckerman

    Version of Record online : 20 OCT 2015, DOI: 10.1111/jvh.12483